Literature DB >> 28375793

Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance.

Ludovico Abenavoli1, Luigi Boccuto2,3.   

Abstract

Recent evidences suggest that adiponectin is a multifunctional hormone, inversely associated with cardiovascular risk factors, such as blood pressure, low-density lipoprotein cholesterol and triglycerides levels. Literature data are conflicting on the serum adiponectin levels in chronic hepatitis C patients. Here we analyze the interesting study of Chang and coworkers, on the dynamic relationship between adiponectin levels and insulin resistance, in chronic hepatitis C patients during viral clearance.

Entities:  

Keywords:  adiponectin; genetic; hepatitis C; insulin resistance; viral clearance

Mesh：

Substances：

Year:  2017        PMID： 28375793      PMCID： PMC5711422          DOI： 10.1080/21505594.2017.1315498

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


  18 in total

1.  The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.

Authors:  Ming-Ling Chang; Chia-Jung Kuo; Li-Heng Pao; Chen-Ming Hsu; Cheng-Tang Chiu
Journal:  Virulence       Date:  2017-03-07       Impact factor: 5.882

Review 2.  Biomarkers of insulin sensitivity and insulin resistance: Past, present and future.

Authors:  Se Eun Park; Cheol-Young Park; Gary Sweeney
Journal:  Crit Rev Clin Lab Sci       Date:  2015-06-04       Impact factor: 6.250

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999.

Authors:  Yukio Arita; Shinji Kihara; Noriyuki Ouchi; Masahiko Takahashi; Kazuhisa Maeda; Jun-ichiro Miyagawa; Kikuko Hotta; Iichiro Shimomura; Tadashi Nakamura; Koji Miyaoka; Hiroshi Kuriyama; Makoto Nishida; Shizuya Yamashita; Kosaku Okubo; Kenji Matsubara; Masahiro Muraguchi; Yasuichi Ohmoto; Tohru Funahashi; Yuji Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  2012-08-31       Impact factor: 3.575

Review 4.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 5.  Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.

Authors:  Valentina Peta; Carlo Torti; Natasa Milic; Alfredo Focà; Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2015-01-27

Review 6.  Adipokines in health and disease.

Authors:  Mathias Fasshauer; Matthias Blüher
Journal:  Trends Pharmacol Sci       Date:  2015-05-25       Impact factor: 14.819

Review 7.  Impact of hepatitis C virus therapy on metabolism and public health.

Authors:  Mitchell L Shiffman; Nadege T Gunn
Journal:  Liver Int       Date:  2017-01       Impact factor: 5.828

Review 8.  Adiponectin as a Target in Obesity-related Inflammatory State.

Authors:  Koji Ohashi; Daisuke Yuasa; Rei Shibata; Toyoaki Murohara; Noriyuki Ouchi
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2015       Impact factor: 2.895

Review 9.  Role of adiponectin system in insulin resistance.

Authors:  Chiara Caselli
Journal:  Mol Genet Metab       Date:  2014-09-16       Impact factor: 4.797

10.  The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.

Authors:  Luca Valenti; Raffaela Rametta; Massimiliano Ruscica; Paola Dongiovanni; Liliana Steffani; Benedetta Maria Motta; Elena Canavesi; Anna Ludovica Fracanzani; Enrico Mozzi; Giancarlo Roviaro; Paolo Magni; Silvia Fargion
Journal:  BMC Gastroenterol       Date:  2012-08-16       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.